CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference ab1a857abb
Drug names112First applicant · distinct drug namesAcceptance records386First applicant · distinct acceptance numbersUnder-review numbers29First applicant · current under-review listCo-applicant records15Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
386 acceptance records as first applicant, grouped into 112 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 9 records · Latest accepted 2026/11/03
New drug · 5Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601351 | New drug | 2026/11/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2601350 | New drug | 2026/11/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500771 | New drug | 2025/07/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500770 | New drug | 2025/07/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2500078 | Supplement | 2025/03/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2500077 | Supplement | 2025/03/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200131 | Supplement | 2022/08/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200130 | Supplement | 2022/08/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2100006 | New drug | 2021/01/08 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/10/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601987 | Supplement | 2026/10/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 7 records · Latest accepted 2026/10/23
New drug · 4Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601320 | New drug | 2026/10/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2601319 | New drug | 2026/10/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2600440 | Supplement | 2026/10/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2500309 | Supplement | 2025/11/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2500308 | Supplement | 2025/11/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400625 | New drug | 2024/06/22 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400624 | New drug | 2024/06/22 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/10/13
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2601107 | New drug | 2026/10/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Caspofungin Acetate for Injection 4 records · Latest accepted 2026/10/09
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601853 | Supplement | 2026/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2601852 | Supplement | 2026/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2150910 | Supplement | 2021/10/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2150909 | Supplement | 2021/10/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/09/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601802 | Supplement | 2026/09/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/09/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600358 | Supplement | 2026/09/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Ixazomib Citrate Capsules 3 records · Latest accepted 2026/08/03
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601883 | Generic | 2026/08/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHS2601882 | Generic | 2026/08/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHS2601881 | Generic | 2026/08/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/31
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600113 | New drug | 2026/07/31 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHS2600112 | New drug | 2026/07/31 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/14
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601676 | Generic | 2026/07/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Guangdong Ke Hong Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2601675 | Generic | 2026/07/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Guangdong Ke Hong Pharma Co., Ltd. romanized | CDE ↗ |
No verified English name 5 records · Latest accepted 2026/07/10
New drug · 3Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600100 | New drug | 2026/07/10 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300448 | New drug | 2023/04/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300446 | New drug | 2023/04/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2300009 | Supplement | 2023/01/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2300008 | Supplement | 2023/01/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/07/09
Supplement · 2New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600220 | Supplement | 2026/07/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2600219 | Supplement | 2026/07/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500138 | New drug | 2025/01/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Anlotinib Hydrochloride Capsules 83 records · Latest accepted 2026/06/01
Supplement · 7New drug · 76
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601043 | Supplement | 2026/06/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2601042 | Supplement | 2026/06/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2601041 | Supplement | 2026/06/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2500102 | New drug | 2025/08/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2500101 | New drug | 2025/08/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2500100 | New drug | 2025/08/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500759 | New drug | 2025/07/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500758 | New drug | 2025/07/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500757 | New drug | 2025/07/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2500035 | New drug | 2025/04/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2500034 | New drug | 2025/04/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2500033 | New drug | 2025/04/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2500032 | New drug | 2025/04/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400120 | New drug | 2024/11/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400119 | New drug | 2024/11/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400118 | New drug | 2024/11/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400108 | New drug | 2024/10/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400107 | New drug | 2024/10/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400106 | New drug | 2024/10/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400069 | New drug | 2024/08/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400068 | New drug | 2024/08/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400067 | New drug | 2024/08/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400295 | New drug | 2024/03/20 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400294 | New drug | 2024/03/20 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400293 | New drug | 2024/03/20 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400018 | New drug | 2024/02/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400017 | New drug | 2024/02/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400016 | New drug | 2024/02/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400008 | New drug | 2024/01/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400007 | New drug | 2024/01/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400006 | New drug | 2024/01/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301405 | New drug | 2023/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301404 | New drug | 2023/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301403 | New drug | 2023/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301375 | New drug | 2023/12/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301374 | New drug | 2023/12/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301373 | New drug | 2023/12/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301334 | New drug | 2023/12/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301333 | New drug | 2023/12/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301332 | New drug | 2023/12/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301276 | New drug | 2023/11/17 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301275 | New drug | 2023/11/17 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301274 | New drug | 2023/11/17 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301272 | New drug | 2023/11/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301271 | New drug | 2023/11/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301270 | New drug | 2023/11/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301269 | New drug | 2023/11/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301268 | New drug | 2023/11/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301075 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301074 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301073 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301072 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2300899 | Supplement | 2023/04/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2300898 | Supplement | 2023/04/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2300897 | Supplement | 2023/04/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300151 | New drug | 2023/02/02 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300150 | New drug | 2023/02/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300149 | New drug | 2023/02/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2300010 | New drug | 2023/01/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2300009 | New drug | 2023/01/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2300008 | New drug | 2023/01/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200386 | New drug | 2022/06/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200385 | New drug | 2022/06/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200384 | New drug | 2022/06/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200066 | New drug | 2022/01/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200065 | New drug | 2022/01/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200064 | New drug | 2022/01/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101552 | New drug | 2021/10/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101551 | New drug | 2021/10/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101550 | New drug | 2021/10/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2101097 | Supplement | 2021/08/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101412 | New drug | 2021/08/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101411 | New drug | 2021/08/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101410 | New drug | 2021/08/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101347 | New drug | 2021/07/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101346 | New drug | 2021/07/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101345 | New drug | 2021/07/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2101012 | New drug | 2021/05/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2101011 | New drug | 2021/05/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2101010 | New drug | 2021/05/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2100128 | New drug | 2021/02/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2100127 | New drug | 2021/02/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2100126 | New drug | 2021/02/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Netupitant and Palonosetron Hydrochloride Capsules 1 records · Latest accepted 2026/05/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601065 | Generic | 2026/05/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/04/28
New drug · 2
No verified English name 1 records · Latest accepted 2026/04/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600825 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600826 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600827 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600828 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/04/16
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600446 | New drug | 2026/04/16 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2600445 | New drug | 2026/04/16 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2600444 | New drug | 2026/04/16 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2600443 | New drug | 2026/04/16 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/03/19
Supplement · 1New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2600108 | Supplement | 2026/03/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXSS2200085 | New drug | 2022/10/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Ceftazidime And Avibactam Sodium For Injection 2 records · Latest accepted 2026/02/14
Supplement · 1Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600360 | Supplement | 2026/02/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2302631 | Generic | 2023/10/08 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2026/02/04
Generic · 2
No verified English name 2 records · Latest accepted 2026/01/27
Supplement · 2
No verified English name 2 records · Latest accepted 2026/01/27
New drug · 2
No verified English name 1 records · Latest accepted 2026/01/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600075 | Generic | 2026/01/08 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/11/18
Supplement · 1New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500310 | Supplement | 2025/11/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101176 | New drug | 2021/06/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101175 | New drug | 2021/06/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 6 records · Latest accepted 2025/11/18
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2501268 | New drug | 2025/11/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2501267 | New drug | 2025/11/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2501266 | New drug | 2025/11/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2501018 | New drug | 2025/09/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2501017 | New drug | 2025/09/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2501016 | New drug | 2025/09/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Sildenafil Citrate Oral Disintegrating Tablets 1 records · Latest accepted 2025/11/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503948 | Generic | 2025/11/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/11/08
Supplement · 2
Esomeprazole Sodium for Injection 4 records · Latest accepted 2025/09/28
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501926 | Supplement | 2025/09/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2501925 | Supplement | 2025/09/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2100089 | Supplement | 2021/01/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2100088 | Supplement | 2021/01/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/09/12
Supplement · 1New drug · 1
Ferumoxytol Injection 3 records · Latest accepted 2025/08/29
Supplement · 2New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500240 | Supplement | 2025/08/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2500239 | Supplement | 2025/08/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200154 | New drug | 2022/03/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/08/09
New drug · 2
No verified English name 1 records · Latest accepted 2025/08/07
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500819 | New drug | 2025/08/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/07/30
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500775 | New drug | 2025/07/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Shanghai Zheng Da Tian Qing Pharmaceuticals Technology Kai Fa Co., Ltd. romanized | CDE ↗ |
| CXHL2500774 | New drug | 2025/07/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Shanghai Zheng Da Tian Qing Pharmaceuticals Technology Kai Fa Co., Ltd. romanized | CDE ↗ |
No verified English name 4 records · Latest accepted 2025/07/09
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2500076 | New drug | 2025/07/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHS2500075 | New drug | 2025/07/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHS2400056 | New drug | 2024/07/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHS2400055 | New drug | 2024/07/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Fulvestrant Injection 5 records · Latest accepted 2025/07/09
New drug · 4Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2500077 | New drug | 2025/07/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHS2400054 | New drug | 2024/07/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300302 | New drug | 2023/03/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300301 | New drug | 2023/03/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2200286 | Supplement | 2022/02/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/03/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501111 | Generic | 2025/03/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Palonosetron Hydrochloride Soft Capsules 1 records · Latest accepted 2025/03/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501009 | Generic | 2025/03/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Umeclidinium Bromide And Vilanterol Trifenatate Powder for Inhalation 1 records · Latest accepted 2025/02/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500678 | Generic | 2025/02/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 8 records · Latest accepted 2025/02/08
Supplement · 1New drug · 7
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500021 | Supplement | 2025/02/08 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500108 | New drug | 2025/01/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2500107 | New drug | 2025/01/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2401274 | New drug | 2024/11/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400821 | New drug | 2024/08/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400820 | New drug | 2024/08/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300527 | New drug | 2023/05/16 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300526 | New drug | 2023/05/16 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Enzalutamide Soft Capsules 1 records · Latest accepted 2025/01/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500542 | Generic | 2025/01/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 6 records · Latest accepted 2024/12/24
Supplement · 1New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2400297 | Supplement | 2024/12/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400530 | New drug | 2024/05/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400357 | New drug | 2024/04/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400161 | New drug | 2024/02/06 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301121 | New drug | 2023/10/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200356 | New drug | 2022/06/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 9 records · Latest accepted 2024/12/19
Supplement · 5New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2400168 | Supplement | 2024/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSB2400167 | Supplement | 2024/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSB2400166 | Supplement | 2024/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSB2400155 | Supplement | 2024/12/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSB2400154 | Supplement | 2024/12/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2400241 | New drug | 2024/04/17 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2400240 | New drug | 2024/04/17 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2300398 | New drug | 2023/06/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2300397 | New drug | 2023/06/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 8 records · Latest accepted 2024/12/03
New drug · 3Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401309 | New drug | 2024/12/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2400191 | Supplement | 2024/09/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400463 | New drug | 2024/05/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2300071 | Supplement | 2023/03/31 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2300070 | Supplement | 2023/03/31 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300180 | New drug | 2023/02/08 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200053 | Supplement | 2022/03/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200052 | Supplement | 2022/03/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/11/13
New drug · 2
No verified English name 3 records · Latest accepted 2024/11/12
Supplement · 2New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2400240 | Supplement | 2024/11/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2400239 | Supplement | 2024/11/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300820 | New drug | 2023/07/26 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Carfilzomib For Injection 1 records · Latest accepted 2024/08/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402817 | Generic | 2024/08/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Metformin Hydrochloride And Empagliflozin Extended Release Tablets 1 records · Latest accepted 2024/08/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402734 | Generic | 2024/08/22 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 13 records · Latest accepted 2024/08/13
New drug · 10Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400823 | New drug | 2024/08/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400822 | New drug | 2024/08/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300119 | New drug | 2023/01/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300118 | New drug | 2023/01/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300117 | New drug | 2023/01/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300115 | New drug | 2023/01/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200836 | New drug | 2022/10/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200835 | New drug | 2022/10/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200765 | New drug | 2022/10/10 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200764 | New drug | 2022/10/10 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200096 | Supplement | 2022/07/02 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2100028 | Supplement | 2021/02/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2100027 | Supplement | 2021/02/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 3 records · Latest accepted 2024/08/09
Supplement · 1New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2400176 | Supplement | 2024/08/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300220 | New drug | 2023/02/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300219 | New drug | 2023/02/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Eltrombopag Olamine Tablets 1 records · Latest accepted 2024/07/26
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401121 | Supplement | 2024/07/26 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 9 records · Latest accepted 2024/07/13
New drug · 8Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2400053 | New drug | 2024/07/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400232 | New drug | 2024/03/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2400231 | New drug | 2024/03/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300809 | New drug | 2023/07/22 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300387 | New drug | 2023/04/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300328 | New drug | 2023/03/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2300038 | Supplement | 2023/02/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200961 | New drug | 2022/12/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200743 | New drug | 2022/09/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/07/09
Supplement · 1Generic · 1
Dasatinib Tablets 2 records · Latest accepted 2024/06/26
Supplement · 2
No verified English name 2 records · Latest accepted 2024/02/09
New drug · 2
No verified English name 2 records · Latest accepted 2024/02/07
New drug · 2
Obeticholic Acid Tablets 2 records · Latest accepted 2024/02/01
Generic · 2
No verified English name 2 records · Latest accepted 2024/01/26
New drug · 2
Degarelix Acetate for Injection 2 records · Latest accepted 2024/01/24
Generic · 2
No verified English name 1 records · Latest accepted 2024/01/05
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400017 | New drug | 2024/01/05 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 4 records · Latest accepted 2023/12/19
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301412 | New drug | 2023/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301410 | New drug | 2023/12/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200027 | New drug | 2022/01/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2200026 | New drug | 2022/01/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 4 records · Latest accepted 2023/11/30
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300243 | Supplement | 2023/11/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300242 | Supplement | 2023/11/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300195 | Supplement | 2023/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300193 | Supplement | 2023/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 6 records · Latest accepted 2023/11/09
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300228 | Supplement | 2023/11/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300227 | Supplement | 2023/11/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300226 | Supplement | 2023/11/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300196 | Supplement | 2023/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300194 | Supplement | 2023/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2300192 | Supplement | 2023/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 4 records · Latest accepted 2023/10/28
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301181 | New drug | 2023/10/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301180 | New drug | 2023/10/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301179 | New drug | 2023/10/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2301178 | New drug | 2023/10/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2023/10/25
Generic · 2
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2023/10/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302890 | Generic | 2023/10/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2023/10/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302891 | Generic | 2023/10/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Docetaxel Injection 1 records · Latest accepted 2023/10/20
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301134 | New drug | 2023/10/20 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 8 records · Latest accepted 2023/10/11
New drug · 6Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2300685 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2300684 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2300683 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2300682 | New drug | 2023/10/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSB2200036 | Supplement | 2022/04/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSB2200035 | Supplement | 2022/04/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2200035 | New drug | 2022/01/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101537 | New drug | 2022/01/05 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/09/14
New drug · 2
No verified English name 1 records · Latest accepted 2023/08/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302255 | Generic | 2023/08/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Eribulin Mesilate Injection 1 records · Latest accepted 2023/08/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302221 | Generic | 2023/08/22 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Eldecalcitol Soft Capsules 2 records · Latest accepted 2023/08/17
Generic · 2
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅰ） 1 records · Latest accepted 2023/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302017 | Generic | 2023/07/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅱ） 1 records · Latest accepted 2023/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302018 | Generic | 2023/07/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Mitiglinide Calcium Tablets 1 records · Latest accepted 2023/07/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350572 | Supplement | 2023/07/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/06/01
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300585 | New drug | 2023/06/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Shou Yao Holding (Beijing) Co., Ltd. romanized | CDE ↗ |
| CXHL2300584 | New drug | 2023/06/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Shou Yao Holding (Beijing) Co., Ltd. romanized | CDE ↗ |
| CXHL2300583 | New drug | 2023/06/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Shou Yao Holding (Beijing) Co., Ltd. romanized | CDE ↗ |
No verified English name 5 records · Latest accepted 2023/04/18
New drug · 4Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300386 | New drug | 2023/04/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300385 | New drug | 2023/04/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200168 | Supplement | 2022/10/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101237 | New drug | 2021/06/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101236 | New drug | 2021/06/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/04/13
Supplement · 1New drug · 1
No verified English name 6 records · Latest accepted 2023/04/07
Supplement · 2New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300082 | Supplement | 2023/04/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2300081 | Supplement | 2023/04/07 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300074 | New drug | 2023/01/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300073 | New drug | 2023/01/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101751 | New drug | 2021/12/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101750 | New drug | 2021/12/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 6 records · Latest accepted 2023/03/18
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300321 | New drug | 2023/03/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300320 | New drug | 2023/03/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300072 | New drug | 2023/01/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2300071 | New drug | 2023/01/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101056 | New drug | 2021/04/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101055 | New drug | 2021/04/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Abiraterone Acetate Tablets 3 records · Latest accepted 2023/03/18
New drug · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300322 | New drug | 2023/03/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2201281 | Supplement | 2022/07/27 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2200384 | Supplement | 2022/03/01 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/02/11
Supplement · 2
Empagliflozin Tablets 1 records · Latest accepted 2023/02/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300273 | Supplement | 2023/02/11 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/01/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300021 | Supplement | 2023/01/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Fosaprepitant Dimeglumine for Injection 1 records · Latest accepted 2023/01/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300003 | Supplement | 2023/01/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 10 records · Latest accepted 2022/09/21
New drug · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2200467 | New drug | 2022/09/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2200039 | New drug | 2022/01/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101521 | New drug | 2021/12/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101363 | New drug | 2021/10/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101357 | New drug | 2021/10/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101276 | New drug | 2021/08/20 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101260 | New drug | 2021/08/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101241 | New drug | 2021/08/12 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101239 | New drug | 2021/08/05 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXSL2101195 | New drug | 2021/07/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 3 records · Latest accepted 2022/07/02
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2200099 | Supplement | 2022/07/02 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200098 | Supplement | 2022/07/02 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHB2200097 | Supplement | 2022/07/02 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Gadoteridol Injection 1 records · Latest accepted 2022/06/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200913 | Generic | 2022/06/20 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Iopromide Injection 2 records · Latest accepted 2022/04/28
Generic · 2
Palbociclib Capsules 3 records · Latest accepted 2022/04/14
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200592 | Generic | 2022/04/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHS2200591 | Generic | 2022/04/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHS2200590 | Generic | 2022/04/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Esomeprazole Magnesium Enteric-Coated Capsules 4 records · Latest accepted 2022/03/29
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200569 | Supplement | 2022/03/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2200568 | Supplement | 2022/03/29 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2101973 | Supplement | 2021/10/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CYHB2101972 | Supplement | 2021/10/15 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Lenvatinib Mesilate Capsules 1 records · Latest accepted 2022/03/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200564 | Supplement | 2022/03/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 5 records · Latest accepted 2022/03/21
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2200090 | Supplement | 2022/03/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYSB2200089 | Supplement | 2022/03/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYSB2200087 | Supplement | 2022/03/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYSB2200086 | Supplement | 2022/03/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYSB2200085 | Supplement | 2022/03/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 3 records · Latest accepted 2022/02/10
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2200017 | Supplement | 2022/02/10 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2200016 | Supplement | 2022/02/10 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2101066 | Supplement | 2021/07/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Everolimus Tablets 1 records · Latest accepted 2022/01/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200216 | Generic | 2022/01/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 3 records · Latest accepted 2022/01/24
Supplement · 1New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2200007 | Supplement | 2022/01/24 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101040 | New drug | 2021/04/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| CXHL2101039 | New drug | 2021/04/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/12/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2101156 | Supplement | 2021/12/17 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Ademetionine 1,4 - Butanedisulfonate For Injection 1 records · Latest accepted 2021/11/19
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2151024 | Supplement | 2021/11/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/11/17
New drug · 2
No verified English name 2 records · Latest accepted 2021/07/30
Supplement · 2
No verified English name 1 records · Latest accepted 2021/07/14
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101291 | New drug | 2021/07/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Sitagliptin Phosphate Tablets 1 records · Latest accepted 2021/06/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101434 | Supplement | 2021/06/28 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Ganirelix Injection 1 records · Latest accepted 2021/06/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101415 | Supplement | 2021/06/18 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/04/27
New drug · 2
No verified English name 2 records · Latest accepted 2021/04/21
New drug · 2
Sitagliptin and Metformin Hydrochloride Extended-release Tablets 1 records · Latest accepted 2021/04/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101046 | Generic | 2021/04/10 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Rivaroxaban Tablets 2 records · Latest accepted 2021/03/19
Supplement · 2
Bendamustine Hydrochloride For Injection 1 records · Latest accepted 2021/02/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2100268 | Supplement | 2021/02/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Linezolid and Glucose Injection 1 records · Latest accepted 2021/01/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2011985 | Supplement | 2021/01/05 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Changes in the last 90 days
12 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Marketing application approved: 1 applicationAccepted: 11 applications
- 2026/11/03Accepted
No verified English name
CXHL2601351
Fact date: 2026/11/03 · Site observation date: 2026/11/04
View source ↗ - 2026/11/03Accepted
No verified English name
CXHL2601350
Fact date: 2026/11/03 · Site observation date: 2026/11/04
View source ↗ - 2026/10/30Accepted
No verified English name
CYHB2601987
Fact date: 2026/10/30 · Site observation date: 2026/10/31
View source ↗ - 2026/10/23Accepted
No verified English name
CXHL2601320
Fact date: 2026/10/23 · Site observation date: 2026/10/24
View source ↗ - 2026/10/23Accepted
No verified English name
CXHL2601319
Fact date: 2026/10/23 · Site observation date: 2026/10/24
View source ↗ - 2026/10/21Accepted
No verified English name
CXHB2600440
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/20Marketing application approved
Umeclidinium Bromide And Vilanterol Trifenatate Powder for Inhalation
CYHS2500678 · 国药准字H20266331
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
View source · Table row 32 ↗ - 2026/10/13Accepted
No verified English name
CXSL2601107
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/09Accepted
Caspofungin Acetate for Injection
CYHB2601853
Fact date: 2026/10/09 · Site observation date: 2026/10/22
View source ↗ - 2026/10/09Accepted
Caspofungin Acetate for Injection
CYHB2601852
Fact date: 2026/10/09 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
CYHB2601802
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/04Accepted
No verified English name
CXHB2600358
Fact date: 2026/09/04 · Site observation date: 2026/10/22
View source ↗
Under review
29 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | CXHL2601351 | New drug | 2026/11/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CXHL2601350 | New drug | 2026/11/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2601987 | Supplement | 2026/10/30 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CXHL2601320 | New drug | 2026/10/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CXHL2601319 | New drug | 2026/10/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CXHB2600440 | Supplement | 2026/10/21 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CXSL2601107 | New drug | 2026/10/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Caspofungin Acetate for Injection | CYHB2601853 | Supplement | 2026/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Caspofungin Acetate for Injection | CYHB2601852 | Supplement | 2026/10/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2601802 | Supplement | 2026/09/23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CXHB2600358 | Supplement | 2026/09/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Ixazomib Citrate Capsules | CYHS2601883 | Generic | 2026/08/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Ixazomib Citrate Capsules | CYHS2601882 | Generic | 2026/08/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Ixazomib Citrate Capsules | CYHS2601881 | Generic | 2026/08/03 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CXHS2600113 | New drug | 2026/07/31 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | CXHS2600112 | New drug | 2026/07/31 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | CYHS2601676 | Generic | 2026/07/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Guangdong Ke Hong Pharma Co., Ltd. romanized | CDE ↗ |
| No verified English name | CYHS2601675 | Generic | 2026/07/14 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Guangdong Ke Hong Pharma Co., Ltd. romanized | CDE ↗ |
| No verified English name | CXHS2600100 | New drug | 2026/07/10 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Netupitant and Palonosetron Hydrochloride Capsules | CYHS2601065 | Generic | 2026/05/09 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2600828 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2600827 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2600826 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2600825 | Supplement | 2026/04/25 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | CYHS2600364 | Generic | 2026/02/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | CYHS2600363 | Generic | 2026/02/04 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHS2600075 | Generic | 2026/01/08 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | CYHS2503948 | Generic | 2025/11/13 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHS2501111 | Generic | 2025/03/19 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
Catalogue holder records
98 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Enzalutamide Soft Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20264860 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palonosetron Hydrochloride Soft Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20264646 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20263671 | 2026/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20263413 | 2026/02/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Degarelix Acetate for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20255342 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20253981 | 2025/04/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20253982 | 2025/04/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20253884 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20253883 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ceftazidime And Avibactam Sodium For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20253156 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eldecalcitol Soft Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20253039 | 2025/01/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eldecalcitol Soft Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20253040 | 2025/01/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20249845 | 2024/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eribulin Mesilate Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20249690 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅱ） | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20249175 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteridol Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20243918 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mitiglinide Calcium Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20120019 | 2024/04/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iopromide Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20243379 | 2024/03/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopromide Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20243378 | 2024/03/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eltrombopag Olamine Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20243006 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Everolimus Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234681 | 2023/12/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234662 | 2023/12/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234609 | 2023/12/05 | Not stated by source | CDE ↗ |
| Palbociclib Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234608 | 2023/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234607 | 2023/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234064 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234065 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin and Metformin Hydrochloride Extended-release Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20233556 | 2023/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ademetionine 1,4 - Butanedisulfonate For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193344 | 2023/03/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Caspofungin Acetate for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193172 | 2022/12/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Caspofungin Acetate for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193173 | 2022/12/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20227139 | 2022/10/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20227140 | 2022/10/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bendamustine Hydrochloride For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20227059 | 2022/04/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Biapenem For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20080743 | 2022/02/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid and Glucose Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20227018 | 2022/02/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字 H20213969 | 2021/12/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20217142 | 2021/12/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lurasidone Hydrochloride Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213865 | 2021/11/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoxetic Acid Disodium Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193162 | 2021/11/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Colistimethate Sodium for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213773 | 2021/10/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trifluridine and Tipiracil Hydrochloride Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213714 | 2021/09/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trifluridine and Tipiracil Hydrochloride Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213715 | 2021/09/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tigecycline for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20133044 | 2021/08/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20183458 | 2021/08/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lenvatinib Mesilate Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213600 | 2021/07/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213597 | 2021/07/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213598 | 2021/07/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tenofovir alafenamide Fumarate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213538 | 2021/06/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fosaprepitant Dimeglumine for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20190030 | 2021/06/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid and Glucose Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20163338 | 2021/05/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sunitinib Hard Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213397 | 2021/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aprepitant Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213328 | 2021/05/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aprepitant Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213329 | 2021/05/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dasatinib Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20133272 | 2021/05/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dasatinib Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20133271 | 2021/05/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Palonosetron Hydrochloride Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20194042 | 2021/04/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Palonosetron Hydrochloride Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20080716 | 2021/04/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Zoledronic Acid Concentrated Solution for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20041346 | 2021/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Zoledronic Acid Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20113138 | 2021/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Decitabine For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20120067 | 2021/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Decitabine For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20143382 | 2021/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Decitabine For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20120066 | 2021/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Docetaxel Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20183209 | 2021/02/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213072 | 2021/01/30 | Not stated by source | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213071 | 2021/01/30 | Not stated by source | CDE ↗ |
| Empagliflozin Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213065 | 2021/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Empagliflozin Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20213066 | 2021/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Parecoxib Sodium for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20183459 | 2021/01/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bortezomib For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20183262 | 2021/01/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bortezomib For Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20183261 | 2021/01/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esomeprazole Sodium for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20163102 | — | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Afatinib Dimaleate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203715 | 2020/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203714 | 2020/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203716 | 2020/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iodixanol Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203629 | 2020/12/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iodixanol Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203628 | 2020/12/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203573 | 2020/11/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203572 | 2020/11/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20163103 | 2020/10/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ganirelix Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20183025 | 2020/10/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Capecitabine Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20143044 | 2020/09/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Canagliflozin Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203498 | 2020/09/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20194079 | 2020/09/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lenalidomide Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20194080 | 2020/09/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Saxagliptin Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203467 | 2020/09/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fulvestrant Injection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203412 | 2020/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Emtricitabine and tenofovir disoproxil fumarate tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203234 | 2020/06/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dabigatran Etexilate Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203098 | 2020/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dabigatran Etexilate Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203097 | 2020/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20203059 | 2020/02/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ticagrelor Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193371 | 2019/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193006 | 2019/10/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tofacitinib Citrate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193281 | 2019/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20193225 | 2019/08/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metformin Hydrochloride Extended-release Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20031104 | 2019/07/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tenofovir Disoproxil Fumarate Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20173303 | 2017/09/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sofosbuvir Tablets | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20223435 | 2022/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
3 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | Y20190005038 | A | 2024/02/24 | CDE ↗ |
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | Y20190004896 | A | 2024/02/24 | CDE ↗ |
| No verified English name | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | Y20190004890 | A | 2024/02/24 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
15 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Sofosbuvir Tablets | CYHB2602039 | Supplement | 2026/11/10 | Sen Long Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHB2602027 | Supplement | 2026/11/09 | Sen Long Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHB2602026 | Supplement | 2026/11/09 | Sen Long Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Loratadine Tablets | CYHB2600184 | Supplement | 2026/01/29 | Jilin Sheng Bai Nian Liu Fu Tang Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2502628 | Generic | 2025/07/22 | Qingdao Guo Xin Pharmaceutical Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2502626 | Generic | 2025/07/22 | Qingdao Guo Xin Pharmaceutical Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2502625 | Generic | 2025/07/22 | Qingdao Guo Xin Pharmaceutical Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Iopromide Injection | CYHB2500989 | Supplement | 2025/05/16 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Iopromide Injection | CYHB2500988 | Supplement | 2025/05/16 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHS2403755 | Generic | 2024/11/05 | Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Aprepitant Capsules | CYHB2400849 | Supplement | 2024/06/21 | Hainan He Rui Da Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Aprepitant Capsules | CYHB2400848 | Supplement | 2024/06/21 | Hainan He Rui Da Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2400489 | Supplement | 2024/04/11 | Hainan He Rui Da Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| No verified English name | CYHB2302680 | Supplement | 2023/12/07 | Zheng Da Tian Qing (Guangzhou) Pharmaceuticals Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
| Tedizolid Phosphate For Injection | CYHS2200529 | Generic | 2022/04/06 | Zheng Da Tian Qing Pharma Group Nanjing Shun Xin Pharmaceutical Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.